Subclinical Atherosclerosis and Subsequent Cognitive Function

Overview

Journal Atherosclerosis

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2015 May 11

PMID 25957568

Citations 20

Authors

Heidi C Rossetti

Myron Weiner

Linda S Hynan

C Munro Cullum

Amit Khera

Laura H Lacritz

Affiliations

Soon will be listed here.

Abstract

Objective: To examine the relationship between measures of subclinical atherosclerosis and subsequent cognitive function.

Method: Participants from the Dallas Heart Study (DHS), a population-based multiethnic study of cardiovascular disease pathogenesis, were re-examined 8 years later (DHS-2) with the Montreal Cognitive Assessment (MoCA); N = 1904, mean age = 42.9, range 8-65. Associations of baseline measures of subclinical atherosclerosis (coronary artery calcium, abdominal aortic plaque, and abdominal aortic wall thickness) with MoCA scores measured at follow-up were examined in the group as a whole and in relation to age and ApoE4 status.

Results: A significant linear trend of successively lower MoCA scores with increasing numbers of atherosclerotic indicators was observed (F(3, 1150) = 5.918, p = .001). CAC was weakly correlated with MoCA scores (p = .047) and MoCA scores were significantly different between participants with and without CAC (M = 22.35 vs 23.69, p = 0.038). With the exception of a small association between abdominal AWT and MoCA in subjects over age 50, abdominal AWT and abdominal aortic plaque did not correlate with MoCA total score (p ≥ .052). Cognitive scores and atherosclerosis measures were not impacted by ApoE4 status (p ≥ .455).

Conclusion: In this ethnically diverse population-based sample, subclinical atherosclerosis was minimally associated with later cognitive function in middle-aged adults.

Citing Articles

Arterial calcification in the heart-brain axis and cognitive performance over time.

Streiber A, van den Beukel T, Vom Hofe I, Neitzel J, Vernooij M, Bos D Alzheimers Dement. 2024; 21(1):e14374.

PMID: 39625064 PMC: 11782186. DOI: 10.1002/alz.14374.

Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice.

Madaudo C, Coppola G, Parlati A, Corrado E Int J Mol Sci. 2024; 25(11).

PMID: 38892201 PMC: 11173271. DOI: 10.3390/ijms25116016.

Polyvascular atherosclerosis and renal dysfunction increase the odds of cognitive impairment in vascular disease: findings of the LipidCardio study.

Konig M, Palmer K, Malsch C, Steinhagen-Thiessen E, Demuth I Eur J Med Res. 2024; 29(1):141.

PMID: 38388510 PMC: 10882759. DOI: 10.1186/s40001-024-01734-6.

Cardiovascular Disease and Alzheimer's Disease: The Heart-Brain Axis.

Saeed A, Lopez O, Cohen A, Reis S J Am Heart Assoc. 2023; 12(21):e030780.

PMID: 37929715 PMC: 10727398. DOI: 10.1161/JAHA.123.030780.

Association between intracranial vessel calcifications, structural brain damage, and cognitive impairment after minor strokes: a prospective study.

Seyman E, Sadeh-Gonik U, Berman P, Blum I, Shendler G, Nathan B Front Neurol. 2023; 14:1218077.

PMID: 37533476 PMC: 10393263. DOI: 10.3389/fneur.2023.1218077.

References

Hallman D, Boerwinkle E, Saha N, Sandholzer C, Menzel H, Csazar A . The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet. 1991; 49(2):338-49. PMC: 1683282. View

Azen S, Mack W, Labree L, Shircore A, Selzer R, Blankenhorn D . Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation. 1996; 93(1):34-41. DOI: 10.1161/01.cir.93.1.34. View

Hofman A, Ott A, Breteler M, Bots M, Slooter A, Van Harskamp F . Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349(9046):151-4. DOI: 10.1016/S0140-6736(96)09328-2. View

Farrer L, Cupples L, Haines J, Hyman B, Kukull W, Mayeux R . Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997; 278(16):1349-56. View

Rosano C, Naydeck B, Kuller L, Longstreth Jr W, Newman A . Coronary artery calcium: associations with brain magnetic resonance imaging abnormalities and cognitive status. J Am Geriatr Soc. 2005; 53(4):609-15. DOI: 10.1111/j.1532-5415.2005.53208.x. View

Nasreddine Z, Phillips N, Bedirian V, Charbonneau S, Whitehead V, Collin I . The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4):695-9. DOI: 10.1111/j.1532-5415.2005.53221.x. View

de Lemos J, Zirlik A, Schonbeck U, Varo N, Murphy S, Khera A . Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol. 2005; 25(10):2192-6. DOI: 10.1161/01.ATV.0000182904.08513.60. View

Kumari M, Marmot M . Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology. 2005; 65(10):1597-603. DOI: 10.1212/01.wnl.0000184521.80820.e4. View

Muller M, Grobbee D, Aleman A, Bots M, van der Schouw Y . Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis. 2006; 190(1):143-9. DOI: 10.1016/j.atherosclerosis.2006.01.005. View

10.

Chui H, Zarow C, Mack W, Ellis W, Zheng L, Jagust W . Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol. 2006; 60(6):677-87. PMC: 1851933. DOI: 10.1002/ana.21009. View

11.

Zadikoff C, Fox S, Tang-Wai D, Thomsen T, de Bie R, Wadia P . A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Mov Disord. 2007; 23(2):297-9. DOI: 10.1002/mds.21837. View

12.

Viswanathan A, Rocca W, Tzourio C . Vascular risk factors and dementia: how to move forward?. Neurology. 2009; 72(4):368-74. PMC: 2677504. DOI: 10.1212/01.wnl.0000341271.90478.8e. View

13.

Gatto N, Henderson V, St John J, McCleary C, Detrano R, Hodis H . Subclinical atherosclerosis is weakly associated with lower cognitive function in healthy hyperhomocysteinemic adults without clinical cardiovascular disease. Int J Geriatr Psychiatry. 2008; 24(4):390-9. PMC: 2661006. DOI: 10.1002/gps.2134. View

14.

de Lemos J, Morrow D, Sabatine M, Murphy S, Gibson C, Antman E . Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003; 107(5):690-5. DOI: 10.1161/01.cir.0000049742.68848.99. View

15.

Jain T, Peshock R, McGuire D, Willett D, Yu Z, Yu Z . African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study. J Am Coll Cardiol. 2004; 44(5):1011-7. DOI: 10.1016/j.jacc.2004.05.069. View

16.

Victor R, Haley R, Willett D, Peshock R, Vaeth P, Leonard D . The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol. 2004; 93(12):1473-80. DOI: 10.1016/j.amjcard.2004.02.058. View

17.

Johnston S, OMeara E, Manolio T, Lefkowitz D, OLeary D, Goldstein S . Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med. 2004; 140(4):237-47. DOI: 10.7326/0003-4819-140-4-200402170-00005. View

18.

Galili O, Herrmann J, Woodrum J, Sattler K, Lerman L, Lerman A . Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 2004; 40(3):529-35. DOI: 10.1016/j.jvs.2004.06.032. View

19.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

20.

Mahley R . Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988; 240(4852):622-30. DOI: 10.1126/science.3283935. View